2017

1. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: A multicenter IMWG study

   Leukemia, Vol. 31, Núm. 11, pp. 2443-2448

2. Second primary malignancies in multiple myeloma: An overview and IMWG consensus

   Annals of Oncology, Vol. 28, Núm. 2, pp. 228-245